Ulrik Niels Lassen
Clinical Professor
- 2013
- Published
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
Lassen, Ulrik Niels, Sorensen, M., Gaziel, T. B., Hasselbalch, B. & Poulsen, H. S., Apr 2013, In: Anticancer Research. 33, 4, p. 1657-60 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment
van Herpen, C. M. L., Lassen, Ulrik Niels, Desar, I. M. E., Brown, K. H., Marotti, M. & de Jonge, M. J. A., 2013, In: Anti-Cancer Drugs. 24, 2, p. 204-11 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours
Lassen, Ulrik Niels, Miller, W. H., Hotte, S., Evans, T. R. J., Kollmansberger, C., Adamson, D., Nielsen, Dorte Lisbet, Spicer, J., Chen, E., Meyer, T., Brown, K., Rafi, R. & Sawyer, M. B., 2013, In: Cancer Chemotherapy and Pharmacology. 71, 2, p. 543-549 7 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
Lassen, Ulrik Niels, Sorensen, M., Gaziel, T. B., Hasselbalch, B. & Poulsen, H. S., 2013, In: Anticancer Research. 33, 4, p. 1657-1660 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma
Spindler, K. G., Sørensen, M., Pallisgaard, N., Andersen, R., Havelund, B. M., Ploen, J., Lassen, Ulrik Niels & Jakobsen, L. A., 2013, In: Acta Oncologica. 52, 5, p. 963-970 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer: A Health Economic Decision Analysis
Søgaard, R., Fischer, Barbara Malene Bjerregaard, Mortensen, Jann, Rasmussen, T. R. & Lassen, Ulrik Niels, 2013, In: Value in Health. 16, 1, p. 57-65 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4952653
Most downloads
-
481
downloads
Clinical trial allocation in multinational pharmaceutical companies: a qualitative study on influential factors
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
224
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
175
downloads
Hallmarks of glioblastoma: a systematic review
Research output: Contribution to journal › Review › Research › peer-review
Published